Sunshine Biopharma Inc. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Sunshine Biopharma Inc. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2014-12-31 was $1.20K.
- Sunshine Biopharma Inc. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2014 was $153.33K, a 21.37% decline from fiscal 2013.
- Sunshine Biopharma Inc. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2013 was $195.00K.
- Sunshine Biopharma Inc. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2010 was $398.60K.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 3 month | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 12 month |
|---|---|---|
| 2014-12-31 | $1.20K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $153.33K 10-K · filed 2015-03-11 |
| 2013-12-31 | $195.00K 10-K · filed 2015-03-11 | |
| 2010-12-31 | $398.60K 10-K · filed 2014-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |